As of June 6, 2021, West Virginia Medicaid will reimburse the administration of Covid-19 monoclonal antibody treatments, billed with M0243, M0245 and M0247 at the Medicare rate of $450.00.
Update!
Due to the high frequency of the Omicron BA.2 sub-variant, the Federal Drug Administration (FDA) announced the product, Sotrovimab (procedure code M0247), is currently NOT authorized in any U.S. region and may not be administered to treat COVID-19 until further notice by the FDA.
For more information, please contact the Bureau for Medical Services at 304-558-1700.